Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.
Angiolillo AL, Davenport V, Bonilla MA, van de Ven C, Ayello J, Militano O, Miller LL, Krailo M, Reaman G, Cairo MS; Children's Oncology Group. Angiolillo AL, et al. Among authors: militano o. Clin Cancer Res. 2005 Apr 1;11(7):2644-50. doi: 10.1158/1078-0432.CCR-04-1959. Clin Cancer Res. 2005. PMID: 15814645 Clinical Trial.
Children's Oncology Group's 2023 blueprint for research: Pharmacy.
Ostrenga AR, Thackray J, McLearan HH, Mulieri KM, Bisaccia E, Militano O, Dupuis LL, Bernhardt MB; COG Pharmacy Discipline Steering Committee. Ostrenga AR, et al. Among authors: militano o. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30581. doi: 10.1002/pbc.30581. Epub 2023 Jul 17. Pediatr Blood Cancer. 2023. PMID: 37460409 Free PMC article.
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Roman E, Cooney E, Harrison L, Militano O, Wolownik K, Hawks R, Foley S, Satwani P, Unal E, Bhatia M, Bradley B, Del Toro G, George D, Garvin J, van de Ven C, Cairo MS. Roman E, et al. Among authors: militano o. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7164s-7170s. doi: 10.1158/1078-0432.CCR-1004-0018. Clin Cancer Res. 2005. PMID: 16203817 Clinical Trial.
Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
Bradley MB, Satwani P, Baldinger L, Morris E, van de Ven C, Del Toro G, Garvin J, George D, Bhatia M, Roman E, Baxter-Lowe LA, Schwartz J, Qualter E, Hawks R, Wolownik K, Foley S, Militano O, Leclere J, Cheung YK, Cairo MS. Bradley MB, et al. Among authors: militano o. Bone Marrow Transplant. 2007 Oct;40(7):621-31. doi: 10.1038/sj.bmt.1705785. Epub 2007 Jul 30. Bone Marrow Transplant. 2007. PMID: 17660841
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.
Waxman IM, Militano O, Baldinger L, Roman E, Qualter E, Morris E, Garvin J, Bradley MB, Bhatia M, Satwani P, George D, Del Toro G, Hawks R, Wolownik K, Foley S, Cheung YK, Schwartz J, van de Ven C, Baxter-Lowe LA, Cairo MS. Waxman IM, et al. Among authors: militano o. Pediatr Transplant. 2009 Jun;13(4):464-74. doi: 10.1111/j.1399-3046.2008.01000.x. Epub 2008 Sep 10. Pediatr Transplant. 2009. PMID: 18785912
An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
Bhatia M, Militano O, Jin Z, Figurski M, Shaw L, Moore V, Morris E, Tallamy B, van deVen C, Ayello J, Baxter-Lowe L, Satwani P, George D, Bradley MB, Garvin J, Cairo MS. Bhatia M, et al. Among authors: militano o. Biol Blood Marrow Transplant. 2010 Mar;16(3):333-43. doi: 10.1016/j.bbmt.2009.10.007. Epub 2009 Oct 14. Biol Blood Marrow Transplant. 2010. PMID: 19835971 Free article. Clinical Trial.
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Zahler S, Bhatia M, Ricci A, Roy S, Morris E, Harrison L, van de Ven C, Fabricatore S, Wolownik K, Cooney-Qualter E, Baxter-Lowe LA, Luisi P, Militano O, Kletzel M, Cairo MS. Zahler S, et al. Among authors: militano o. Biol Blood Marrow Transplant. 2016 Apr;22(4):698-704. doi: 10.1016/j.bbmt.2016.01.019. Epub 2016 Jan 16. Biol Blood Marrow Transplant. 2016. PMID: 26785332 Free article. Clinical Trial.
Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients.
Militano O, Ozkaynak MF, Mehta B, van deVen C, Hamby C, Cairo MS. Militano O, et al. Pediatr Blood Cancer. 2018 Aug;65(8):e27091. doi: 10.1002/pbc.27091. Epub 2018 Apr 18. Pediatr Blood Cancer. 2018. PMID: 29667720 Clinical Trial.
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia.
Hochberg J, Zahler S, Geyer MB, Chen N, Krajewski J, Harrison L, Militano O, Ozkaynak MF, Cheerva AC, Talano J, Moore TB, Gillio AP, Walters MC, Baxter-Lowe LA, Hamby C, Cairo MS. Hochberg J, et al. Among authors: militano o. Bone Marrow Transplant. 2019 Feb;54(2):226-235. doi: 10.1038/s41409-018-0247-9. Epub 2018 Jun 13. Bone Marrow Transplant. 2019. PMID: 29899571 Free article. Clinical Trial.
20 results